Socio-economic impacts of pandemic influenza mitigation scenarios in Slovakia

Ekonomicky casopis

Volumn 57, Issue 2, 2009, Pages 163-178

  Brunovský, Pavol ^a   Ševčovič, Daniel ^a   Somorčík, Ján ^a   Hroncová, Dagmar ^b   Pospíšilová, Kateřina ^c,d  

^a Physics and Informatics   (Slovakia)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Univerzita Pavla Jozefe afárika v Ko iciach Lekárska fakulta Klinika pre infek né choroby   (Slovakia)

^d Fakultná nemocnica L Pasteura ^*  (Slovakia)

Author keywords

Influenza; Mitigation; Monte Carlo; Pandemia

Indexed keywords

DISEASE CONTROL; ECONOMIC IMPACT; EPIDEMIC; INFLUENZA; MITIGATION; MONTE CARLO ANALYSIS; MORTALITY; SOCIOECONOMIC IMPACT; STOCHASTICITY;

CENTRAL EUROPE; EURASIA; EUROPE; SLOVAKIA;

EID: 65349155928     PISSN: 00133035     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. BERAN, J. - HAVLÍK, J. (2005): Chřipka - klinický obraz, prevence, léčba. Praha: Maxdorf, pp. 10 - 17.
2. DOYLE, A. - BONMARTN, I. - LÉVY-BRUHL, D. - LE STRAT, Y. - DESENCLOS, J. C. (2006): Infuenza Pandemic Preparedness in France: Modelling the Impact of Interventions. Journal of Epidemiol Community Health, 60, pp. 399 - 404.
3. FERGUSON, N. M. et al. (2006): Strategies for Mitigating an Influenza Pandemic. Nature, 442, pp. 448-452.
4. FRASER, C. - RILEY, S. - ANDERSON, R. M. - FERGUSON, N. M. (2004): Factors that Make an Infectious Disease Outbreak Controllable. PNAS, 101, pp. 6146 - 6151.
5. GERMANN, T. C. - KADAU, K. - LONGIN1, I. M. - MACKEN, C. A. (2006): Mitigation Strategies for Pandemic Influenza in the United States. PNAS, 103, pp. 5935 - 5940.
6. GOLD, M. R. et al. (1996): Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
7. HAK, E. et al. (2006): Modelling the Health - Economic Impact of the Next Influenza Pandemic in the Netherlands. Vaccine, 24, pp. 6756 - 6760.
8. LAZZARI, S. - STÖHR, K. (2004): Avian Influenza and Influenza Pandemics. Bulletin WHO, 82, pp. 242 - 243.
9. LEROUX, I. R. et al. (2007): Antigen Sparing and Cross- Reactive Immunity with an Adjuvanted rH5Nl Prototype Pandemic Vaccine a Randomized Controlled Trial. Lancet, 370, pp. 580 - 589.
10. LONGINI, I. M. et al. (2005): Containing Pandemic Influenza at the Source. Science, 309, pp. 1083 - 1087.
11. MELTZER, M. - COX, N. - FUKUDA, K. (1999): The Economic Impact of Pandemic Influenza in the United Sates: Priorities for Intervention. Emerg. Infect. Dis., 5, pp. 659 - 671.
12. Pandemic Plan of Czech Republic 2006. Available at: .
13. TAUBENBERGER, J. K. - MORENS, D. M. (2006): 1918 Influenza: The Mother of All Pandemics. Emerg. Infect. Dis., 12, pp. 15 - 22.
14. VAN GENUGTEN, M. L. - HEIJNEN, M. L. - JAGER J. C. (2003): Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario Analysis. Emerg. Infect. Dis., 9, pp. 531 - 538.
15. WHO (2008a): Cumulative Number of Confirmed Human Cases of Avian Influenza A (H5N1) Reported to WHO. Available at: .
16. WHO (2008b): Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus: Update on Avian Influenza A (H5N1) Virus Infection in Humans. New England Journal of Medicine, 358, pp. 261 - 273.